(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DIALYVITE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DIALYVITE

ST13

US500000074070175

Class

5

Filing

74070175

Registration

1659396

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

01/10/2021

Trademark type

Word

Nice classes

5

Filing date

06/18/1990

Registration date

10/08/1991

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/10/2021

Last transaction

01/10/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

08/10/1988

First use in commerce

09/21/1989

Drawing code

1

Owner type

03

Owner location

WOODRUFF, WI, US

Examiner

WHITAKER, LAURIE

Law office

G50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

HILLESTAD PHARMACEUTICALS USA, INC.
Hillestad International Inc.

Representatives

Thomas Schneck Law Offices of Thomas Schneck

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

physician-prescribed multi-vitamin supplements for renal care patients

Publications

History of USPTO decisions and trademark events.

25 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/10/2021

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

01/10/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/10/2021

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

01/04/2021

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

01/02/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/29/2020

E89R

TEAS SECTION 8 & 9 RECEIVED

10/08/2020

CORV

REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED

12/09/2019

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

12/06/2019

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

10/07/2011

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/07/2011

E89R

TEAS SECTION 8 & 9 RECEIVED

10/01/2011

CFIT

CASE FILE IN TICRS

11/23/2007

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/20/2001

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/20/2001

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

08/06/2001

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/05/1996

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

10/24/1996

R.PR

REGISTERED-PRINCIPAL REGISTER

10/08/1991

PUBO

PUBLISHED FOR OPPOSITION

07/16/1991

NPUB

NOTICE OF PUBLICATION

06/14/1991

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/27/1991

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/24/1990

CNRT

NON-FINAL ACTION MAILED

11/16/1990

DOCK

ASSIGNED TO EXAMINER

10/25/1990

Continuous trademark protection

Get notified about every new filing that threatens DIALYVITE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.